Hypertension in young and middle - aged adults, a big problem that should be paid great attention in China

doi:10.3969/j.issn.1672-6731.2022.10.001

Abstract

Abstract: In the past 2 decades, there is rapid grow on the proportion of abnormal blood pressure (BP, including high normal BP and hypertension grade 1-3) in young and middle-aged Chinese population. On the contrary, the awareness, treatment and control of hypertension are obviously low. Overweight, inactivity, unhealthy eating habits, alcoholism, smoking and sleep insufficiency are the main causes of abnormal BP in young and middle-aged adults. At the same time, the incidence of hypertension attributable cardiovascular diseases (coronary heart disease, stroke) show a rapid upward trend in the young and middle-aged adults. Although the proportion of ischemic stroke in young and middle - adults is much higher than that of hemorrhagic stroke in absolute numbers, the growth rate of hemorrhagic stroke is accelerating, which composes a major threat to the health of young and middle - adults. As the base of hypertensive cerebral hemorrhage, cerebral small vessel disease has different manifestations in the formation and development stages of stroke, and has significant clinical risk indication and prognosis prediction value. Extensive screening should be advocated in young and middle?aged adults with abnormal BP.

Key words: Hypertension, Young adult, Middle aged, Stroke, Cerebral small vessel diseases, Review

摘要： 近20年来我国中青年人群血压异常（正常血压高值、高血压1 ~ 3级）比例迅速增加，但高血压知晓率、治疗率和血压控制率仍普遍偏低。超重/肥胖、运动不足、不健康饮食、饮酒、吸烟、睡眠不足是造成中青年人群血压异常的主要原因。与此同时，高血压相关心脑血管疾病在中青年人群中呈快速上升趋势，虽然中青年缺血性卒中病例数和比例远高于出血性卒中，但出血性卒中的增长比例呈加速上升趋势。脑小血管病作为高血压脑出血的基础病变，在脑卒中发生发展过程中表现不同，具有重要的风险和预后预测价值，因此，有必要在中青年血压异常人群中进行广泛的脑小血管病检查。

关键词: 高血压, 青年人, 中年人, 卒中, 大脑小血管疾病, 综述

ZHUO Jie, ZHI Da-shi. Hypertension in young and middle - aged adults, a big problem that should be paid great attention in China[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2022, 22(10): 829-835.

卓杰, 只达石. 应高度重视我国中青年高血压[J]. 中国现代神经疾病杂志, 2022, 22(10): 829-835.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2022.10.001

https://journal11.magtechjournal.com/cjcnn/EN/Y2022/V22/I10/829

References

[1] State Statiscs Bureau, Office of The State Council Leading Group for the Seventh National Census. Seventh National Censu Bulletin (No. 5)[EB/OL]. (2021-05-11)[2022-10-22]. http://www.stats.gov.cn/xxgk/sjfb/zxfb2020/202105/t20210511_1817200.html. 国家统计局, 国务院第七次全国人口普查领导小组办公室. 第七次全国人口普查公报(第五号)[EB/OL]. (2021-05-11)[2022-10-22]. http://www.stats.gov.cn/xxgk/sjfb/zxfb2020/202105/t20210511_1817200.html
[2] Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/ AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. J Am Coll Cardiol, 2018, 71: e127-248.
[3] Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017-2018[J]. NCHS Data Brief, 2020, (364): 1-8.
[4] Peng Y. The impact of 2017 ACC/AHA guideline on the prevalence of hypertension in Australia[J]. J Hum Hypertens, 2021, 35: 104-106.
[5] Gupta K, Ramakrishnan S, Zachariah G, Rao JS, Mohanan PP, Venugopal K, Sateesh S, Sethi R, Jain D, Bardolei N, Mani K, Kakar TS, Jain V, Gupta P, Gupta R, Bansal S, Nath RK, Tyagi S, Wander GS, Gupta S, Mandal S, Senguttuvan NB, Subramanyam G, Roy D, Datta S, Ganguly K, Routray SN, Mishra SS, Singh BP, Bharti BB, Das MK, Deb PK, Deedwania P, Seth A; CSI - Great India BP Campaign Investigators. Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: results from a cross-sectional survey[J]. Int J Cardiol Hypertens, 2020, 7: 100055.
[6] Sadeghi F, Cheraghian B, Mohammadi Z, Sepanlou SG, Masoudi S, Rahimi Z, Danehchin L, Paridar Y, Abolnezhadian F, Noori M, Mard SA, Shayesteh AA, Poustchi H. Impact of 2017 ACC/ AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population - based cross - sectional study in southwest of Iran[J]. Popul Health Metr, 2021, 19: 26.
[7] Li D, Zeng X, Huang Y, Lei H, Li G, Zhang N, Huang W. Increased risk of hypertension in young adults in southwest China: impact of the 2017 ACC/AHA high blood pressure guideline[J]. Curr Hypertens Rep, 2019, 21: 21.
[8] Cho SMJ, Lee H, Kim HC. Comparison and implication of the contemporary blood pressure guidelines on Korean population[J]. Korean Circ J, 2020, 50: 485-498.
[9] Zheng L, Dai Y, Fu P, Yang T, Xie Y, Zheng J, Gao J, Niu T. Secular trends of hypertension prevalence based on 2017 ACC/ AHA and 2018 Chinese hypertension guidelines: results from CHNS data (1991-2015)[J]. J Clin Hypertens (Greenwich), 2021, 23: 28-34.
[10] Writing Group of 2018 Chinese Guidelines for the Management of Hypertension; Chinese Hypertension League, Cardiovascular Branch, Chinese Medical Society; Hypertension Committee, Chinese Medical Doctor Association; Hypertension Branch, China International Exchange and Promotive Association for Medical and Health Care; Hypertension Branch, Chinese Geriatric Medical Association. 2018 Chinese guidelines for the management of hypertension[J]. Zhongguo Xin Xue Guan Za Zhi, 2019, 24: 24-56. 中国高血压防治指南修订委员会, 高血压联盟(中国)中华医学会心血管病学分会, 中国医师协会高血压专业委员会, 中国医疗保健国际交流促进会高血压分会, 中国老年医学学会高血压分会. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24: 24-56.
[11] Xi B, Liang Y, Reilly KH, Wang Q, Hu Y, Tang W. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991-2009[J]. Int J Cardiol, 2012, 158: 326-329.
[12] Zhang M, Wu J, Zhang X, Hu CH, Zhao ZP, Li C, Huang ZJ, Zhou MG, Wang LM. Prevalence and control of hypertension in adults in China, 2018[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2021, 42: 1780-1789. 张梅, 吴静, 张笑, 胡彩红, 赵振平, 李纯, 黄正京, 周脉耕, 王丽敏. 2018年中国成年居民高血压患病与控制状况研究[J]. 中华流行病学杂志, 2021, 42: 1780-1789.
[13] Ma S, Yang L, Zhao M, Magnussen CG, Xi B. Trends in hypertension prevalence, awareness, treatment and control rates among Chinese adults, 1991-2015[J]. J Hypertens, 2021, 39: 740-748.
[14] NCD Risk Factor Collaboration (NCD - RisC). Long - term and recent trends in hypertension awareness, treatment, and control in 12 high - income countries: an analysis of 123 nationally representative surveys[J]. Lancet, 2019, 394: 639-651.
[15] Zhou BF; Cooperative Meta - Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut - off points of body mass index and waist circumference in Chinese adults[J]. Biomed Environ Sci, 2002, 15: 83-96.
[16] Li X, Niu H, Bai X, Wang Y, Wang W. Association of obesity and hypertension: a cohort study in China[J]. Int J Hypertens, 2021: ID1607475.
[17] Luo X, Yang H, He Z, Wang S, Li C, Chen T. Numbers and mortality risk of hypertensive patients with or without elevated body mass index in China[J]. Int J Environ Res Public Health, 2021, 19: 116.
[18] Zhu Z, Tang Y, Zhuang J, Liu Y, Wu X, Cai Y, Wang L, Cao ZB, Chen P. Physical activity, screen viewing time, and overweight/obesity among Chinese children and adolescents: an update from the 2017 physical activity and fitness in China - the youth study[J]. BMC Public Health, 2019, 19: 197.
[19] Yang S, Guo B, Ao L, Yang C, Zhang L, Zhou J, Jia P. Obesity and activity patterns before and during COVID - 19 lockdown among youths in China[J]. Clin Obes, 2020, 10: e12416.
[20] Li R, Zhang S, Li Q, Meng Q, Zu C, Zhang Y, He P, Liu M, Zhou C, Ye Z, Wu Q, Yang S, Zhang Y, Liu C, Qin X. Transportation physical activity and new - onset hypertension: a nationwide cohort study in China[J]. Hypertens Res, 2022, 45: 1430-1440.
[21] Li Y, Zhang P, Wu J, Ma J, Xu J, Zhang X, Luo R, Liu M, Sun Y, Li X, Tan M, He FJ, MacGregor GA, Li X. Twenty-four-hour urinary sodium and potassium excretion and their associations with blood pressure among adults in China: baseline survey of action on salt China[J]. Hypertension, 2020, 76: 1580-1588.
[22] World Health Organization. Guideline: sodium intake for adults and children[M]. Geneva: WHO Press, 2012[2019 - 12 - 10]. https://www.ncbi.nlm.nih.gov/books/NBK133309/
[23] Xu A, Ma J, Guo X, Wang L, Wu J, Zhang J, Bai Y, Xu J, Lu Z, Xu Z, Zhang X, Ding G, Hong Y, Du F, Wu Y, Yan L, Tang J, Cai X, Dong J, Xu C, Ren J, Chen X, Gao C, Zhang B, Yang Q, Moolenaar R, Cai Y, Jackson SL, Xie G, Yu S, Cui J, Wang Z, Zhao L, Ju L, Shen D, Yun S, Liang X, Bi Z, Wang Y. Association of a province -wide intervention with salt intake and hypertension in Shandong Province, China, 2011-2016[J]. JAMA Intern Med, 2020, 180: 877-886.
[24] MacDonald CJ, Madika AL, Bonnet F, Fagherazzi G, Lajous M, Boutron - Ruault MC. Cholesterol and egg intakes, and risk of hypertension in a large prospective cohort of French women[J]. Nutrients, 2020, 12: 1350.
[25] Chen MM, Huang X, Xu C, Song XH, Liu YM, Yao D, Lu H, Wang G, Zhang GL, Chen Z, Sun T, Yang C, Lei F, Qin JJ, Ji YX, Zhang P, Zhang XJ, Zhu L, Cai J, Wan F, She ZG, Li H. High remnant cholesterol level potentiates the development of hypertension[J]. Front Endocrinol (Lausanne), 2022, 13: 830347.
[26] He D, Sun N, Xiong S, Qiao Y, Ke C, Shen Y. Association between the proportions of carbohydrate and fat intake and hypertension risk: findings from the China Health and Nutrition Survey[J]. J Hypertens, 2021, 39: 1386-1392.
[27] Qi SF, Cao YJ, Wang HJ, Zhang B, Yan J, Tian QB. Associations of carbohydrate intake with new -onset hypertension subtypes: results from the China Health and Nutrition Survey (2000-2011)[J]. Front Nutr, 2022, 8: 728774.
[28] Zhao F, Liu Q, Li Y, Feng X, Chang H, Lyu J. Association between alcohol consumption and hypertension in Chinese adults: findings from the CHNS[J]. Alcohol, 2020, 83: 83-88.
[29] Dochi M, Sakata K, Oishi M, Tanaka K, Kobayashi E, Suwazono Y. Smoking as an independent risk factor for hypertension: a 14 - year longitudinal study in male Japanese workers[J]. Tohoku J Exp Med, 2009, 217: 37-43.
[30] Aryanpur M, Yousefifard M, Oraii A, Heydari G, Kazempour - Dizaji M, Sharifi H, Hosseini M, Jamaati H. Effect of passive exposure to cigarette smoke on blood pressure in children and adolescents: a meta - analysis of epidemiologic studies[J]. BMC Pediatr, 2019, 19: 161.
[31] Feng X, Liu Q, Li Y, Zhao F, Chang H, Lyu J. Longitudinal study of the relationship between sleep duration and hypertension in Chinese adult residents (CHNS 2004-2011)[J]. Sleep Med, 2019, 58: 88-92.
[32] Shulman R, Cohen DL, Grandner MA, Gislason T, Pack AI, Kuna ST, Townsend RR, Cohen JB. Sleep duration and 24-hour ambulatory blood pressure in adults not on antihypertensive medications[J]. J Clin Hypertens (Greenwich), 2018, 20: 1712 - 1720.
[33] Wang JX, Zhang Y, Liu YY; SLEEMON Sleep Research Institute. Annual sleep report of China 2022[M]. Beijing: Social Science Academic Press (China), 2022. 王俊秀, 张衍, 刘洋洋; 喜临门睡眠研究院. 《中国睡眠研究报告(2022)》[M]. 北京: 社会科学文献出版社, 2022.
[34] Pan RY, Zhang LJ, Tao SH, Lu N, Cai XF, Liu MY. Present situation of hypertension, insomnia, anxiety and depression in young and middle - aged scientific workers[J]. Zhongguo Xun Zheng Xin Xue Guan Yi Xue Za Zhi, 2022, 14: 308-312. 潘若愚, 张丽军, 陶淑慧, 鲁楠, 才秀芬, 刘梅颜. 中青年科技工作者高血压与失眠、焦虑抑郁现状分析[J]. 中国循证心血管医学杂志, 2022, 14: 308-312.
[35] Liu J, Bu X, Wei L, Wang X, Lai L, Dong C, Ma A, Wang T. Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019[J]. J Hypertens, 2021, 39: 2488-2496.
[36] Luo D, Cheng Y, Zhang H, Ba M, Chen P, Li H, Chen K, Sha W, Zhang C, Chen H. Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis[J]. BMJ, 2020, 370: m3222.
[37] Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2020 update. A report from the American Heart Association[J]. Circulation, 2020, 141: e139-596.
[38] Tib?k M, Dehlendorff C, J?rgensen HS, Forchhammer HB, Johnsen SP, Kammersgaard LP. Increasing incidence of hospitalization for stroke and transient ischemic attack in young adults: a registry - based study[J]. J Am Heart Assoc, 2016, 5: e003158.
[39] Hussain A, Lee M, Rana J, Virani SS. Epidemiology and risk factors for stroke in young individuals: implications for prevention[J]. Curr Opin Cardiol, 2021, 36: 565-571.
[40] Bako AT, Pan A, Potter T, Tannous J, Johnson C, Baig E, Meeks J, Woo D, Vahidy FS. Contemporary trends in the nationwide incidence of primary intracerebral hemorrhage[J]. Stroke, 2022, 53: e70-74.
[41] Gedansky A, Jarvis P, Yu D, Lu X, Heiman - Patterson T, Linares G. Intracerebral hemorrhage in a young urban population: etiologies and outcomes in patients 50 and younger[J]. J Stroke Cerebrovasc Dis, 2019, 28: 104295.
[42] Yang NR, Kim JH, Ahn JH, Oh JK, Chang IB, Song JH. Is nontraumatic intracerebral hemorrhage different between young and elderly patients[J]? Neurosurg Rev, 2020, 43: 781-791.
[43] Mustanoja S, Putaala J, Koivunen RJ, Surakka I, Tatlisumak T. Blood pressure levels in the acute phase after intracerebral hemorrhage are associated with mortality in young adults[J]. Eur J Neurol, 2018, 25: 1034-1040.
[44] Khawaja AM, Shiue H, Boehme AK, Albright KC, Venkatraman A, Kumar G, Lyerly MJ, Hays - Shapshak A, Mirza M, Gropen TI, Harrigan MR. Admission systolic blood pressure predicts the number of blood pressure medications at discharge in patients with primary intracerebral hemorrhage[J]. Neurologist, 2018, 23: 60-64.
[45] Periole C, Blanc C, Calvière L, Fontaine L, Viguier A, Albucher JF, Chollet F, Bonneville F, Olivot JM, Raposo N. Prevalence and characterization of cerebral small vessel disease in young adults with intracerebral hemorrhage[J]. Int J Stroke, 2022. [Epub ahead of print]
[46] Reddy ST, Savitz SI. Hypertension - related cerebral microbleeds[J]. Case Rep Neurol, 2020, 12: 266-269.
[47] Xia Y, Wang Y, Yang L, Wang Y, Liang X, Zhao Q, Wu J, Chu S, Liang Z, Ding H, Ding D, Cheng X, Dong Q. Incident cerebral microbleeds and hypertension defined by the 2017 ACC/AHA guidelines[J]. Ann Transl Med, 2021, 9: 314.
[48] Lyu L, Shen J, Zeng C, Ji J, Hu W, Wei T, Mao W. Cerebral microbleeds are associated with blood pressure levels in individuals with hypertension[J]. Clin Exp Hypertens, 2020, 42: 328-334.
[49] Soo Y, Abrigo JM, Leung KT, Tsang SF, Ip HL, Ma SH, Ma K, Fong WC, Li SH, Li R, Ng PW, Wong KK, Liu W, Lam BYK, Wong KSL, Mok V, Chu WCW, Leung TW; IPAAC Study Group. Risk of intracerebral haemorrhage in Chinese patients with atrial fibrillation on warfarin with cerebral microbleeds: the IPAAC - Warfarin study[J]. J Neurol Neurosurg Psychiatry, 2019, 90: 428-435.
[50] Ni R, Chu L, Xu D, Li Y, Li Y, Zhang Y, You M, Zhu Y, Ouyang F, Zhang J, Cai G, Lin X, Yang Z, Gao Z. Risk factors of cerebral microbleeds in young and middle -aged patients with hypertension[J]. Neurol Res, 2018, 40: 413-418.
[51] Liang C, Wang J, Feng M, Zhang N, Guo L. White matter changes, duration of hypertension, and age are associated with cerebral microbleeds in patients with different stages of hypertension[J]. Quant Imaging Med Surg, 2022, 12: 119-130.
[52] Neurology Branch, Chinese Medical Association; Cerebral Vascular Disease Group, Neurology Branch, Chinese Medical Association. Chinese consensus on diagnosis and treatment of cerebral small vessel disease[J]. Zhonghua Shen Jing Ke Za Zhi, 2015, 48: 838-844. 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑小血管病诊治共识[J]. 中华神经科杂志, 2015, 48: 838-844.
[53] Xu M, Cheng Y, Zhang S, Zhang S, Song Q, Zheng L, Liu M, Liu M. Higher cerebral small vessel disease burden is associated with smaller hematoma volume in mixed - location intracerebral hemorrhage[J]. Microcirculation, 2021, 28: e12705.
[54] Guo W, Meng L, Lin A, Lin Y, Fu Y, Chen W, Li S. Implication of cerebral small - vessel disease on perihematomal edema progress in patients with hypertensive intracerebral hemorrhage[J]. J Magn Reson Imaging, 2022. [Epub ahead of print]
[55] Pasi M, Sugita L, Xiong L, Charidimou A, Boulouis G, Pongpitakmetha T, Singh S, Kourkoulis C, Schwab K, Greenberg SM, Anderson CD, Gurol ME, Rosand J, Viswanathan A, Biffi A. Association of cerebral small vessel disease and cognitive decline after intracerebral hemorrhage[J]. Neurology, 2021, 96: e182-192.
[56] Pasi M, Boulouis G, Fotiadis P, Auriel E, Charidimou A, Haley K, Ayres A, Schwab KM, Goldstein JN, Rosand J, Viswanathan A, Pantoni L, Greenberg SM, Gurol ME. Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease[J]. Neurology, 2017, 88: 2162-2168.
[57] Park YS, Chung MS, Choi BS. MRI Assessment of cerebral small vessel disease in patients with spontaneous intracerebral hemorrhage[J]. Yonsei Med J, 2019, 60: 774-781.
[58] Lee YM, Koo HW, Kang HK, Kim JW, Han SR, Yoon SW, Choi CY, Sohn MJ, Lee CH. The Prevalence and characterization of cerebral microbleeds in young people having intracerebral hemorrhage[J]. J Cerebrovasc Endovasc Neurosurg, 2018, 20: 112-119.

Please choose a citation manager

Content to export